BSX
BOSTON SCIENTIFIC CORP
NYSE · Healthcare · Medical - Devices · US
$45.05
+1.49%Forward multiples
Based on analyst estimates
- P/E forward
- 13.52x
- P/E 2026E
- 13.77x
- P/E 2027E
- 13.21x
- P/E 2028E
- 11.97x
- P/S forward
- 2.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- 18.17x
- PEG TTM
- 0.53x
- Price / book
- 2.62x
- Price / sales
- 3.11x
- Price / cash flow
- 14.42x
Enterprise value
- Enterprise value
- $77.6B
- EV / sales
- 3.70x
- EV / EBITDA
- 13.37x
- EV / EBIT
- 17.22x
- Market cap
- $65.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026